Thus, low-dose artesunate not only prevented the opposite, although moderate alterations in the subcellular localization of α2 and α3 GlyR clusters observed in APP/PS1 mice in comparison to WT, which might be part of the early remodeling process of inhibitory neurotransmission in AD, but even corrected these parameters over WT levels. Here, APP is linked to Alzheimer disease.